Transactions
4
Insider / HEALTHEQUITY, INC.
Rajasekar Sunil
EVP Chief Prod & Strat Officer at HEALTHEQUITY, INC.
- Company
- HEALTHEQUITY, INC.
- Ticker
- HQY
- First filing on record
- October 19, 2026
- Latest trade on record
- October 15, 2026
- SEC filings
- EDGAR ↗
Rajasekar Sunil, EVP Chief Prod & Strat Officer at HEALTHEQUITY, INC., has disclosed 4 transactions in HQY since October 19, 2026: 2 purchases (2 open-market buys) and 2 sales, worth about $25K at the reported prices. The latest was filed October 19, 2026, 4 days after the trade; 3 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
2
Sales
2
Avg. disclosure lag
85.8d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)
In the last 12 months Rajasekar Sunil made 2 purchases worth $12K and 2 sales worth $13K. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Rajasekar Sunil has traded 1 stock on record; the largest by dollars is HQY.
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| P | Open-market purchase | 2 | 131 | $12K |
| S | Open-market sale | 2 | 131 | $13K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 4 | 2 · $12K | 2 · $13K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| HQY | Buy P | October 15, 2026 | October 19, 2026 | 4d | 108 | $90 | $9,756 | Form 4 ↗ | ||
| HQY | Sell S | August 24, 2026 | October 19, 2026 | 56d | 108 | $106 | $11K | late | Form 4 ↗ | |
| HQY | Buy P | July 8, 2026 | October 19, 2026 | 103d | 23 | $95 | $2,186 | late | Form 4 ↗ | |
| HQY | Sell S | April 22, 2026 | October 19, 2026 | 180d | 23 | $83 | $1,905 | late | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 19, 2026 | Form 4 | 0001934884-26-000007 | 4 | published | EDGAR ↗ |
Other insiders at HEALTHEQUITY, INC.
- Ladd Delano EVP, General Counsel 12 rows
- Neeleman Stephen FOUNDER AND VICE CHAIRMAN 12 rows
- Fiore Michael Henry EVP, CHIEF COMMERCIAL OFFICER 10 rows
- Rosner Elimelech EVP, CHIEF TECHNOLOGY OFFICER 7 rows
- Wellborn Gayle Furgurson Director 7 rows
- Lucania James M EVP & CFO 6 rows
- Cutler Scott President and CEO 5 rows
- DILLON ADRIAN T Director 5 rows
- Gathright Michael Chief Customer Officer 3 rows
- Dilsaver Evelyn S Director 2 rows
Everyone on file, with contracts and lobbying under the company's name: HEALTHEQUITY, INC..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 1 | 4 | October 19, 2026 | October 19, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.